|
The U.S. life sciences industry and the real estate that it occupies have ridden a wave of momentum into this year that has positioned various industry hubs, from cornerstones such as Boston to emerging hotspots like Seattle, for outsized growth, according to a new report from CBRE.
Numerous indicators point to robust expansion for the industry, including the 86 percent increase in venture-capital funding for U.S. life sciences companies to $15.8 billion for the year ended in September from the previous year. Additionally, life sciences lab space under construction in the industry’s five largest U.S. markets expanded by 101 percent last year to 6.0 million sq. ft.
That momentum has several markets ascendant on CBRE’s ranking of the top established and emerging life sciences hubs. New York City, for example, stands to nearly double its inventory of lab space over the next two years, has posted the strongest growth in funding from the National Institutes of Health among major life sciences hubs, and boasts one of the highest concentrations of specialized life scientists.
“Multiple demographic, scientific and financial factors have propelled life sciences into growing faster than most other industries in the early part of this century, and many U.S. markets are well equipped to facilitate and capitalize on that growth,” said Ian Anderson, CBRE Director of Research and Analysis and primary author of the report. “Those likely to stay at the top of that list, or to rise on it, have an uncommon combination of health institutions and universities, a qualified workforce, a pipeline of industry funding, an ample base of lab space, and a solid technology industry to partner with life sciences companies.”
CBRE’s report focuses on the human life-sciences industry, which encompasses manufacturing, testing and research-and-development work in the fields of biotechnology, pharmaceuticals and medical devices.
CBRE analyzed and ranked the top established life sciences hubs by weighing four main criteria for each market: number of scientists in key industry categories, industry funding for local life sciences companies, size and long-term growth of their life sciences workforce, and their inventory of industry lab space.
Top 10 Established Life Sciences Markets
| 1.) Boston-Cambridge |
6.) Washington, D.C.-Baltimore |
| 2.) San Francisco Bay Area |
7.) New York City |
| 3.) San Diego |
8.) Philadelphia |
| 4.) New Jersey |
9.) Los Angeles |
| 5.) Raleigh-Durham |
10.) Chicago |
Beyond the established hubs, CBRE analyzed the next tier of emerging hubs to determine which are climbing quickly up the national ranks. CBRE ranked the emerging hubs based on their three-year growth in life sciences employment; NIH funding; quality and quantity of educational institutions for life sciences studies; number of medical research and health-services institutions; and their depth of high-tech workers. Nine met the criteria to be ranked as fast-growing, emerging hubs.
Top Emerging Life Sciences Hubs
| 1.) Seattle |
6.) Denver |
| 2.) Houston |
7.) Dallas-Fort Worth |
| 3.) Austin |
8.) Atlanta |
| 4.) Minneapolis |
9.) Pittsburgh |
| 5.) St. Louis |
|
“Multiple indicators point to sustained, strong growth for the life sciences industry, which makes life sciences labs and offices an ideal focus for developers and investors,” said Steve Purpura, Vice Chairman leading CBRE’s Life Sciences business. “Few industries offer this much expansion potential, but much of the activity happens in a select number of special markets.”
To read the full report, click here. This is a large file; Please allow several seconds for it to download.
|
Disinfectant Dispensers in Healthcare Facilities Often Fail to Deliver Safe Concentrations: Study
Duke University Health System Receives $50 Million for Proton Beam Therapy Center
UT Southwestern Experiences Data Breach Through Calendar Tool
Protecting Patient Data: Strategies and Tactics
Duke Health to Acquire Lake Norman Regional Medical Center